{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:47:44Z","timestamp":1759229264429},"reference-count":11,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Laboratorios LEO Pharma, SA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1111\/dth.12344","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T19:21:44Z","timestamp":1457810504000},"page":"236-239","source":"Crossref","is-referenced-by-count":8,"title":["Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients"],"prefix":"10.1155","volume":"29","author":[{"given":"M.","family":"Salleras Redonnet","sequence":"first","affiliation":[{"name":"Servicio de Dermatolog\u00eda, QUIRON-Salut Hospital Sagrat Cor. Universidad de Barcelona; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Quintana Codina","sequence":"additional","affiliation":[{"name":"Servicio de Dermatolog\u00eda, QUIRON-Salut Hospital Sagrat Cor. Universidad de Barcelona; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"10.1111\/dth.12344-BIB0001|dth12344-cit-0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.12766","article-title":"British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014","volume":"170","author":"Morton","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12344-BIB0002|dth12344-cit-0002","first-page":"CD007281","article-title":"Interventions for cutaneous Bowen's disease","volume":"6","author":"Bath-Hextall","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/dth.12344-BIB0003|dth12344-cit-0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07610.x","article-title":"Guidelines for management of Bowen's disease: 2006 update","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12344-BIB0004|dth12344-cit-0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1586\/edm.12.13","article-title":"Ingenol mebutate (ingenol 3-angelate, PEP005): focus on its uses in the treatment of nonmelanoma skin cancer","volume":"7","author":"Lebwohl","year":"2012","journal-title":"Expert Rev Dermatol"},{"key":"10.1111\/dth.12344-BIB0005|dth12344-cit-0005","doi-asserted-by":"crossref","first-page":"965.e1","DOI":"10.1016\/j.jaad.2013.12.045","article-title":"Topical pharmacotherapy for skin cancer","volume":"70","author":"Micali","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12344-BIB0006|dth12344-cit-0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13555-014-0061-2","article-title":"Ingenol mebutate: a succinct review of a succinct therapy","volume":"4","author":"Alchin","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1111\/dth.12344-BIB0007|dth12344-cit-0007","doi-asserted-by":"crossref","first-page":"979.e1","DOI":"10.1016\/j.jaad.2013.12.037","article-title":"Topical pharmacotherapy for skin cancer","volume":"70","author":"Micali","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12344-BIB0008|dth12344-cit-0008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1684\/ejd.2014.2368","article-title":"The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP)","volume":"24","author":"Tzogani","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1111\/dth.12344-BIB0009|dth12344-cit-0009","unstructured":"Garbe C Larsson T Venkata R 2014"},{"key":"10.1111\/dth.12344-BIB0010|dth12344-cit-0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13555-014-0051-4","article-title":"Recurrent in situ melanoma successfully treated with ingenol mebutate","volume":"4","author":"Mansuy","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1111\/dth.12344-BIB0011|dth12344-cit-0011","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00105-014-3509-5","article-title":"Erfolgreiche Behandlung eines Morbus Bowen mit Ingenolmebutat","volume":"65","author":"Braun","year":"2014","journal-title":"Hautarzt"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12344","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12344\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:55:49Z","timestamp":1671818149000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12344"}},"subtitle":["Bowen disease treated with ingenol mebutate"],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12344","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}